United Health Products (OTCMKTS:UEEC) versus Envoy Medical (NASDAQ:COCH) Critical Comparison

United Health Products (OTCMKTS:UEEC) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for United Health Products and Envoy Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United Health Products	0	0	0	0	N/A
Envoy Medical	0	0	3	0	3.00

Envoy Medical has a consensus target price of $7.25, indicating a potential upside of 208.51%. Given Envoy Medical’s higher possible upside, analysts plainly believe Envoy Medical is more favorable than United Health Products.

Risk and Volatility

United Health Products has a beta of -0.37, meaning that its stock price is 137% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500.

Profitability

This table compares United Health Products and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United Health Products	N/A	N/A	-600.31%
Envoy Medical	N/A	N/A	-112.11%

Earnings and Valuation

This table compares United Health Products and Envoy Medical’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United Health Products	$40,000.00	1,101.52	-$2.62 million	N/A	N/A
Envoy Medical	$320,000.00	143.94	-$29.91 million	N/A	N/A

United Health Products has higher earnings, but lower revenue than Envoy Medical.

Insider & Institutional Ownership

0.1% of United Health Products shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 1.5% of United Health Products shares are held by company insiders. Comparatively, 0.7% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Envoy Medical beats United Health Products on 6 of the 9 factors compared between the two stocks.

About United Health Products

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.